Thoracic Cancer

Challenges in diagnosing and treating NUT carcinoma 1:32
Challenges in diagnosing and treating NUT carcinoma
Jia Luo • 20 Sep 2023
Optimal chemotherapy regimens for NUT carcinoma 3:00
Optimal chemotherapy regimens for NUT carcinoma
Jia Luo • 20 Sep 2023
An overview of NUT carcinomas 1:53
An overview of NUT carcinomas
Jia Luo • 20 Sep 2023
Multi-modality treatment in thoracic PNET 4:31
Multi-modality treatment in thoracic PNET
Akif Turna • 29 Aug 2023
Radiotherapy highlights at TTLC 2022 1:06
Radiotherapy highlights at TTLC 2022
Charles Simone • 28 Feb 2022
Optimizing CAR T-cell therapies for thoracic cancers 1:28
Optimizing CAR T-cell therapies for thoracic cancers
Prasad Adusumilli • 8 Mar 2022
The role of radiotherapy in mesothelioma and thymic carcinoma 1:29
The role of radiotherapy in mesothelioma and thymic carcinoma
Charles Simone • 28 Feb 2022
Proton therapy in thoracic cancer and mesothelioma 1:27
Proton therapy in thoracic cancer and mesothelioma
Charles Simone • 28 Feb 2022
Nintedanib plus steroid taper in radiation pneumonitis 3:11
Nintedanib plus steroid taper in radiation pneumonitis
Zachary Moore • 14 Sep 2021
Impact of autoimmune disease co-occurring with thymic epithelial tumors and Good’s syndrome 3:09
Impact of autoimmune disease co-occurring with thymic epithelial tumors and Good’s syndrome
Margaret Ottaviano • 2 Feb 2021
ccfDNA to monitor the biological course of thymic epithelial tumors 3:43
ccfDNA to monitor the biological course of thymic epithelial tumors
Margaret Ottaviano • 2 Feb 2021
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results 2:28
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results
Yannis Metaxas • 29 Sep 2019
Tackling urgent questions in EGFRm NSCLC 2:44
Tackling urgent questions in EGFRm NSCLC
Nicolas Girard • 8 Sep 2017
Toxicity: immunotherapy vs chemotherapy 2:09
Toxicity: immunotherapy vs chemotherapy
Benjamin Besse • 8 Sep 2017
Exciting results from the ALEX trial 2:23
Exciting results from the ALEX trial
Silvia Novello • 8 Sep 2017
The content of VJOncology is intended for healthcare professionals